R&D No longer the little fish: How Europe is holding its own thr... It goes without saying that we are living in uncertain times, yet, this holds particularly true for the pharmaceutical industry.
Digital Sponsored Scaling AI in life sciences: From automation to strategic tr... When talking about AI in pharma and life sciences marketing, we often focus on the automation of content creation, management, and delivery.
R&D Driving data & analytics transformation in life sciences The field of life sciences is witnessing a remarkable era of innovation, characterised by breakthroughs across scientific domains that are revolutionising drug discovery and development.
Partner Content Partner Content Wilmington Healthcare wins first client for new NHS transfor... Product helps pharma identify opportunities and tailor
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.